Diffusion-Weighted Imaging of Orbital Masses: Multi-Institutional Data Support a 2-ADC Threshold Model to Categorize Lesions as Benign, Malignant, or Indeterminate

BACKGROUND AND PURPOSE: DWI has been increasingly used to characterize orbital masses and provides quantitative information in the form of the ADC, but studies of DWI of orbital masses have shown a range of reported sensitivities, specificities, and optimal threshold ADC values for distinguishing benign from malignant lesions. Our goal was to determine the optimal use of DWI for imaging orbital masses through aggregation of data from multiple centers. MATERIALS AND METHODS: Source data from 3 previous studies of orbital mass DWI were aggregated, and additional published data points were gathered. Receiver operating characteristic analysis was performed to determine the sensitivity, specificity, and optimal ADC thresholds for distinguishing benign from malignant masses. RESULTS: There was no single ADC threshold that characterized orbital masses as benign or malignant with high sensitivity and specificity. An ADC of less than 0.93 × 10−3 mm2/s was more than 90% specific for malignancy, and an ADC of less than 1.35 × 10−3 mm2/s was more than 90% sensitive for malignancy. With these 2 thresholds, 33% of this cohort could be characterized as “likely malignant,” 29% as “likely benign,” and 38% as “indeterminate.” CONCLUSIONS: No single ADC threshold is highly sensitive and specific for characterizing orbital masses as benign or malignant. If we used 2 thresholds to divide these lesions into 3 categories, however, a majority of orbital masses can be characterized with >90% confidence.

[1]  A. Razek,et al.  Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging , 2011, Neuroradiology.

[2]  Arzu Arslan,et al.  MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates. , 2005, European journal of radiology.

[3]  M. Mafee,et al.  Lacrimal gland tumors and simulating lesions. Clinicopathologic and MR imaging features. , 1999, Radiologic clinics of North America.

[4]  A. Moll,et al.  Single-Shot Turbo Spin-Echo Diffusion-Weighted Imaging for Retinoblastoma: Initial Experience , 2012, American Journal of Neuroradiology.

[5]  A. Flanders,et al.  Ocular Adnexal Lymphoma: Diffusion-weighted MR Imaging for Differential Diagnosis and Therapeutic Monitoring , 2011 .

[6]  C. Specht,et al.  From the archives of the AFIP: Pediatric orbit tumors and tumorlike lesions: neuroepithelial lesions of the ocular globe and optic nerve. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[7]  M. Mafee,et al.  OPTIC NERVE SHEATH MENINGIOMAS: Role of MR Imaging , 1999 .

[8]  G. Valvassori,et al.  Imaging of orbital lymphoproliferative disorders. , 1999, Radiologic clinics of North America.

[9]  Z. C. Wang,et al.  MRI study of solitary fibrous tumor in the orbit. , 2012, AJR. American journal of roentgenology.

[10]  W. Smoker,et al.  Vascular lesions of the orbit: more than meets the eye. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[11]  C. Meyer,et al.  Diffusion coefficient measurement using a temperature‐controlled fluid for quality control in multicenter studies , 2011, Journal of magnetic resonance imaging : JMRI.

[12]  T. Yoshiura,et al.  Intraorbital lobular capillary hemangioma (pyogenic granuloma) , 2008, Radiation Medicine.

[13]  M. Shiehmorteza,et al.  Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. , 2010, Radiology.

[14]  J. Villablanca,et al.  Diffusion-Weighted Imaging of Malignant Ocular Masses: Initial Results and Directions for Further Study , 2012, American Journal of Neuroradiology.

[15]  A. Razek Diffusion-Weighted Magnetic Resonance Imaging of Head and Neck , 2010, Journal of computer assisted tomography.

[16]  M. Mafee,et al.  Sarcoidosis of the eye, orbit, and central nervous system. Role of MR imaging. , 1999, Radiologic clinics of North America.

[17]  Z. Khademian,et al.  Magnetic resonance imaging in the analysis of pediatric orbital tumors: utility of diffusion-weighted imaging. , 2010, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[18]  S. Mukherji,et al.  Differentiation of Benign and Malignant Pathology in the Head and Neck Using 3T Apparent Diffusion Coefficient Values: Early Experience , 2008, American Journal of Neuroradiology.

[19]  S. Ansari,et al.  Anatomy and pathology of the eye: role of MR imaging and CT. , 2006, Neuroimaging clinics of North America.

[20]  C. Shields,et al.  Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. , 2004, Ophthalmology.

[21]  M. Mafee,et al.  MR Imaging of Orbital Inflammatory Syndrome, Orbital Cellulitis, and Orbital Lymphoid Lesions: The Role of Diffusion-Weighted Imaging , 2008, American Journal of Neuroradiology.

[22]  M. Shahin,et al.  MRI in Diagnosis of Orbital Masses , 2010, Current eye research.

[23]  M. Mafee,et al.  Peripheral nerve tumors of the orbit. , 1999, Radiologic clinics of North America.

[24]  Stephan E Maier,et al.  Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. , 2005, AJNR. American journal of neuroradiology.

[25]  Kei Yamada,et al.  Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. , 2008, Radiology.

[26]  M. Mafee,et al.  MRI of orbital cellulitis and orbital abscess: the role of diffusion-weighted imaging. , 2009, AJR. American journal of roentgenology.

[27]  Y. Bilgili,et al.  Effect of region of interest on interobserver variance in apparent diffusion coefficient measures. , 2004, AJNR. American journal of neuroradiology.